Sunovion Pharmaceuticals Inc.

Sumitomo Pharma America, Inc.

Robert Joseph Prytko

Haitao Zhang

Shahla Jamzad

Andrea Bauer

Michael Joseph Sizensky

Xiaoxia Chen

Harold Scott Wilkinson

Nandkumar Nivritti Bhogle

John R Snoonian

Kostas Saranteas

Takahiko Hashizuka

Provided are salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various of crystal forms thereof, and compositions, medicaments, pharmaceutically acceptable formulations thereof, and methods of making same. In addition, provided are compounds comprising specific particle size distributions of crystalline (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine HCl and methods of making and modulating the particle size distributions.

Salts, crystal forms, and production methods thereof

The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.

Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof

Growing community of inventors

Millbury, MA, United States of America

Robert Joseph Prytko